Cargando…

Safety and immunogenicity of Sinovac’s prototype pandemic influenza H5N1 vaccines: a review on clinical trials

Abstract Sinovac Biotech started to develop prototype pandemic influenza H5N1 vaccines in March 2004. On 2 April 2008, Sinovac’s inactivated, aluminium‐adjuvanted, whole‐virion prototype pandemic influenza A (H5N1) vaccine (PanFlu™) was granted production licensure by the China regulatory authority...

Descripción completa

Detalles Bibliográficos
Autores principales:	Qiu, Yuan‐Zheng, Yin, Wei‐Dong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Blackwell Publishing Ltd 2008
Materias:	Reviews
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4634113/ https://www.ncbi.nlm.nih.gov/pubmed/19453400 http://dx.doi.org/10.1111/j.1750-2659.2008.00067.x

Ejemplares similares

Immunogenicity and safety of pandemic influenza A (H1N1) 2009 vaccine: systematic review and meta‐analysis
por: Yin, J. Kevin, et al.
Publicado: (2011)

Profile: Sinovac
por: Yang, Helen
Publicado: (2013)

Safety and Immunogenicity of H5N1 Influenza Vaccine Based on Baculovirus Surface Display System of Bombyx mori
por: Jin, Rongzhong, et al.
Publicado: (2008)

Adverse event of Sinovac Coronavirus vaccine: Deafness
por: Zhao, Hai, et al.
Publicado: (2022)

Immunogenicity and Safety of an AS03-Adjuvanted H7N9 Pandemic Influenza Vaccine in a Randomized Trial in Healthy Adults
por: Madan, Anuradha, et al.
Publicado: (2016)

Immunogenicity decay and case incidence six months post Sinovac-CoronaVac vaccine in autoimmune rheumatic diseases patients
por: Silva, Clovis A., et al.
Publicado: (2022)

Evaluation of the Safety and Immunogenicity of a Candidate Pandemic Live Attenuated Influenza Vaccine (pLAIV) Against Influenza A(H7N9)
por: Sobhanie, Mahdee, et al.
Publicado: (2016)

Preclinical immunogenicity assessment of a cell-based inactivated whole-virion H5N1 influenza vaccine
por: Zhang, Zhegang, et al.
Publicado: (2022)

Meta-Analysis of the Immunogenicity and Tolerability of Pandemic Influenza A 2009 (H1N1) Vaccines
por: Manzoli, Lamberto, et al.
Publicado: (2011)

The safety and immunogenicity of a MF59-adjuvanted H5N1 prepandemic influenza vaccine in healthy adults primed with homologous or heterologous H5N1 vaccines: an observational study
por: Wei, Sung-Hsi, et al.
Publicado: (2014)

Safety, Reactogenicity, and Immunogenicity of Inactivated Monovalent Influenza A(H5N1) Virus Vaccine Administered With or Without AS03 Adjuvant
por: Chen, Wilbur H., et al.
Publicado: (2014)

Comparative safety, immunogenicity, and efficacy of several anti‐H5N1 influenza experimental vaccines in a mouse and chicken models (Testing of killed and live H5 vaccine)
por: Gambaryan, Alexandra S., et al.
Publicado: (2011)

Sinovac COVID-19 vaccine–induced cutaneous leukocytoclastic vasculitis
por: Bencharattanaphakhi, Rungrot, et al.
Publicado: (2021)

Impact of anti-rheumatic treatment on immunogenicity of pandemic H1N1 influenza vaccine in patients with arthritis
por: Kapetanovic, Meliha C, et al.
Publicado: (2014)

Safety and immunogenicity of live attenuated influenza reassortant H5 vaccine (phase I–II clinical trials)
por: Rudenko, Larisa, et al.
Publicado: (2008)

Immunogenicity of H5N1 influenza vaccines in elderly adults: a systematic review and meta-analysis
por: Zhang, Ke, et al.
Publicado: (2020)

Sinovac vaccination and the course of COVID-19 disease in hospitalized patients in Turkey
por: Delen, Leman Acun, et al.
Publicado: (2022)

Construction and Immunogenicity of a Novel Multivalent Vaccine Prototype Based on Conserved Influenza Virus Antigens
por: Kirsteina, Anna, et al.
Publicado: (2020)

Immunogenicity and safety of subunit influenza vaccines in pregnant women
por: Kostinov, Mikhail P., et al.
Publicado: (2018)

Safety and immunogenicity of synchronous COVID19 and influenza vaccination
por: Baj, Andreina, et al.
Publicado: (2022)

Immunogenicity and safety of coadministration of COVID-19 and influenza vaccination
por: Wagenhäuser, Isabell, et al.
Publicado: (2023)

Immunogenicity and Efficacy of Flagellin-Fused Vaccine Candidates Targeting 2009 Pandemic H1N1 Influenza in Mice
por: Liu, Ge, et al.
Publicado: (2011)

Immunogenicity of Virus Like Particle Forming Baculoviral DNA Vaccine against Pandemic Influenza H1N1
por: Gwon, Yong-Dae, et al.
Publicado: (2016)

Safety and immunogenicity of 3 seasonal trivalent influenza vaccines in the Chinese military
por: Gao, Dongqi, et al.
Publicado: (2016)

SARS-COV-2-vaccine-inactivated-Sinovac-Biotech/tozinameran: Various toxicities: 5 case reports
Publicado: (2022)

Shoulder injury related to Sinovac COVID-19 vaccine: A case report
por: Chuaychoosakoon, Chaiwat, et al.
Publicado: (2021)

SARS-COV-2-vaccine-inactivated-Sinovac-Biotech: Carditis: case report
Publicado: (2022)

Sars-cov-2-vaccine-inactivated-sinovac-biotech: Myeloradiculitis: case report
Publicado: (2022)

Manifestations of adverse events post Sinovac vaccine immunization at Wirasakti Hospital, Kupang
por: Basri, Aries Hasan, et al.
Publicado: (2023)

Rapidly produced SAM(®) vaccine against H7N9 influenza is immunogenic in mice
por: Hekele, Armin, et al.
Publicado: (2013)

Glycosylation generates an efficacious and immunogenic vaccine against H7N9 influenza virus
por: Kim, Jin Il, et al.
Publicado: (2020)

Monitoring the safety of influenza A/H1N1 pandemic and seasonal vaccines in Morocco
por: Tebaa, Amina, et al.
Publicado: (2022)

Evaluating the immunogenicity and safety of a BiondVax-developed universal influenza vaccine (Multimeric-001) either as a standalone vaccine or as a primer to H5N1 influenza vaccine: Phase IIb study protocol
por: van Doorn, Eva, et al.
Publicado: (2017)

Confronting Potential Influenza A (H5N1) Pandemic with Better Vaccines
por: Haque, Azizul, et al.
Publicado: (2007)

Impact of Preexisting Adenovirus Vector Immunity on Immunogenicity and Protection Conferred with an Adenovirus-Based H5N1 Influenza Vaccine
por: Pandey, Aseem, et al.
Publicado: (2012)

Preservation of the Immunogenicity of Dry-powder Influenza H5N1 Whole Inactivated Virus Vaccine at Elevated Storage Temperatures
por: Geeraedts, Felix, et al.
Publicado: (2010)

A Rapid Flp-In System for Expression of Secreted H5N1 Influenza Hemagglutinin Vaccine Immunogen in Mammalian Cells
por: Lu, Hanxin, et al.
Publicado: (2011)

A phase II, open-label, multicentre study to evaluate the immunogenicity and safety of an adjuvanted prepandemic (H5N1) influenza vaccine in healthy Japanese adults
por: Nagai, Hideaki, et al.
Publicado: (2010)

Effects of Prior Influenza Exposure on Immunogenicity of Influenza Vaccine
por: Cao, Jia-Qian, et al.
Publicado: (2020)

Low immunogenicity of whole virion, verocell-derived, inactivated, pandemic influenza H1N1 vaccine in HIV-infected patients
por: Lagler, H, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_vgeganpjolsph7gqthvdkl527n